NexLife vs Enhance.MD: pricing, doses and services compared
NexLife and Enhance.MD serve different priorities. NexLife: NexLife bundles medication, clinician care, laboratory review, support and expedited shipping into one flat price with n… Enhance.MD: Flat pricing at every dose, with a dedicated microdose tirzepatide programme at $169/month (1mg/week, delivered every 12… There is no universal winner — the right choice depends on whether you optimize for lowest starter price, flat dose pricing, or bundled clinical services. Figures reflect status as of July 12, 2026.
Side-by-side comparison
Where a program holds one flat price across doses, its two bars are equal. Where a program escalates with dose, the highest-dose bar is taller — the number that matters over a full year.
| Factor | NexLife | Enhance.MD |
|---|---|---|
| Starting price | $147/mo (microdose) Verified | $169/mo (microdose tirz) Reported — pending verification |
| Renewal price | $186/mo full-dose (12-mo); $215 month-to-month Verified | $212 sema; $280 tirz (12-mo) Reported — pending verification |
| Highest-dose price | Flat — no dose-based increase Verified | Flat at all doses Reported — pending verification |
| Membership | $0 Verified | $0 Reported — pending verification |
| Labs | Lab review included Verified | Lab testing included Reported — pending verification |
| Shipping | Included (expedited) Verified | Free Reported — pending verification |
| Commitment | 12-month or month-to-month Verified | 12-month for best rate Reported — pending verification |
| Pharmacy | Network disclosed: Red Rock, Hallandale, Absolute, Empower, DIRx (licences not yet independently verified by us) Verified | Not independently verified Reported — pending verification |
| Clinician | Medical Director: Adam Kennah, MD (NPI 1144260043, provider-supplied) Verified | Provider care included Reported — pending verification |
| States | All 50 states, synchronous and asynchronous visits Verified | Pending research Reported — pending verification |
Winner by decision factor
We never let one provider win every category — that pattern is the signature of a manipulated comparison.
| Decision factor | Better fit |
|---|---|
| Lowest advertised starter price | NexLife |
| Best all-inclusive value | NexLife |
| Clearest pharmacy disclosure | Depends / tie |
| Best month-to-month flexibility | NexLife |
NexLife: who it fits
NexLife bundles medication, clinician care, laboratory review, support and expedited shipping into one flat price with no membership fee and no dose-based escalation. Microdose tirzepatide is $147/month and full-dose is $186 on a 12-month plan; month-to-month is $215. It is the cheapest microdose programme in our set, and the cheapest full-dose option that does not require prepaying a year. Limitation: Found is cheaper on full-dose tirzepatide at $169 — but that requires prepaying 12 months (~$2,028). Oak Longevity is cheaper on semaglutide at $133. NexLife offers no brand pathway and no insurance coordination. Full NexLife review →
Enhance.MD: who it fits
Flat pricing at every dose, with a dedicated microdose tirzepatide programme at $169/month (1mg/week, delivered every 12 weeks). Standard tirzepatide is $280 and semaglutide $212 on the 12-month plan. Limitation: Standard tirzepatide at $280 is close to brand Zepbound's $299. The old flat $49/$99 first-month promos were retired in 2026. Full Enhance.MD review →
Frequently asked questions
Is NexLife or Enhance.MD cheaper?
On starting price: NexLife is $147/mo (microdose) and Enhance.MD is $169/mo (microdose tirz). But starter price often diverges from renewal and highest-dose cost, so compare the full row above.
How were these figures verified?
Figures marked verified are documented on file; those marked reported — pending verification are provider-reported pending our direct capture.
Sources
- Both providers' pricing and terms pages, captured July 12, 2026.
- Our price-normalization methodology.
- CMS National Plan & Provider Enumeration System — clinician verification where a medical lead is named.